XML 57 R42.htm IDEA: XBRL DOCUMENT v3.24.4
ASSET PURCHASE AGREEMENT - Schedule of consideration paid for asset acquisition (Details) - Spindle R N A P enzyme platform 1 technology
Jul. 12, 2023
USD ($)
$ / shares
shares
ASSET PURCHASE AGREEMENT  
Cash $ 625,000
37,500 Company shares at $25.40/share (share price on July 12, 2023) 952,500
Direct transaction costs 437,360
Total consideration paid for acquiring Spindle RNAP enzyme platform $ 2,014,860
Number of shares issued as consideration | shares 37,500
Share issue price | $ / shares $ 25.4